Skip to main content
. 2019 Jun 21;14:4461–4474. doi: 10.2147/IJN.S205276

Table 3.

Single dose and multi-dose toxicity studies of VCR liposome formulations in rats

Dose Formulations Dead/treated Day of death
Single-dose 3 mg/kg GVM 4/6 (67%) 6, 6, 7, 8
SRLV-1 3/6 (50%) 6, 7, 10
SRLV-2 0/6 (0) /
SRLV-3 1/6 (17%) 7
4 mg/kg GVM 6/6 (100%) 4, 4, 5, 5, 6, 6
SRLV-1 6/6 (100%) 5, 5, 6, 6, 6, 9
SRLV-2 1/6 (17%) 6
SRLV-3 3/6 (50%) 5, 6, 6
5 mg/kg GVM 6/6 (100%) 2, 3, 3, 3, 4, 4
SRLV-1 6/6 (100%) 3, 3, 4, 4, 4, 5
SRLV-2 6/6 (100%) 4, 5, 5, 5, 6, 7
SRLV-3 6/6 (100%) 3, 4, 4, 5, 5, 5
Multi-dose 1 mg/kg/day * 5 days GVM 10/10 (100%) 4, 6, 7, 7, 7, 8, 8, 8, 8,10
SRLV-1 10/10 (100%) 8, 9, 10, 10, 11, 11, 11, 12, 12, 16
SRLV-2 4/10 (40%) 10,11,11,13
SRLV-3 6/10 (60%) 9, 9, 10, 11, 12, 14

Notes: The fraction is the proportion of animals per group dying within 14 days after last dose of a specified formulation at a given dose level. Percentage group mortality is in parentheses. Death were recorded from day 0 to 14 days after the last dose. The fraction is the proportion of animals per group dying within 14 days after last dose of a specified formulation at a given dose level. Percentage group mortality is in parentheses.